Total Payments
$2,120
2024 Payments
$64.01
Companies
11
Transactions
49
Medicare Patients
8,246
Medicare Billing
$473,128
Payment Breakdown by Category
Food & Beverage$1,367 (64.5%)
Travel$739.30 (34.9%)
Education$13.89 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,367 | 43 | 64.5% |
| Travel and Lodging | $739.30 | 5 | 34.9% |
| Education | $13.89 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,210 | 22 | $0 (2024) |
| Abbott Laboratories | $228.18 | 4 | $0 (2020) |
| ABIOMED | $208.43 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $161.46 | 5 | $0 (2024) |
| Medtronic Vascular, Inc. | $126.12 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $83.55 | 4 | $0 (2021) |
| Medtronic, Inc. | $30.56 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $30.39 | 2 | $0 (2022) |
| Amgen Inc. | $14.55 | 1 | $0 (2020) |
| Cardinal Health 200 LLC | $13.56 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.01 | 3 | Boston Scientific Corporation ($28.32) |
| 2023 | $87.04 | 3 | ABIOMED ($55.53) |
| 2022 | $58.19 | 3 | ABIOMED ($31.47) |
| 2021 | $65.37 | 3 | Janssen Pharmaceuticals, Inc ($39.46) |
| 2020 | $256.01 | 8 | Abbott Laboratories ($180.87) |
| 2019 | $1,331 | 18 | Boston Scientific Corporation ($1,067) |
| 2018 | $258.64 | 11 | BOSTON SCIENTIFIC CORPORATION ($114.49) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: General - Therapies_CRM | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/21/2023 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Stents | ||||||
| 03/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Obesity | ||||||
| 02/08/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $55.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2021 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $39.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2021 | Cardinal Health 200 LLC | — | Food and Beverage | In-kind items and services | $13.56 | General |
| 11/18/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/11/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiology | ||||||
| 09/22/2020 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $133.61 | General |
| Category: Vascular | ||||||
| 09/22/2020 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Vascular | ||||||
| 09/07/2020 | Abbott Laboratories | Supera peripheral stent system (Device) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Vascular | ||||||
| 06/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/20/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/30/2019 | Boston Scientific Corporation | ROTABLATOR (Device) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: ATHERECTOMY | ||||||
| 05/07/2019 | Medtronic Vascular, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $126.12 | General |
| Category: Transcatheter Valve Systems | ||||||
| 05/04/2019 | Abbott Laboratories | Perclose ProGlide suture mediated closure system (Device) | Food and Beverage | In-kind items and services | $47.31 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,995 | 2,575 | $342,541 | $108,828 |
| 2022 | 18 | 2,036 | 2,680 | $324,913 | $123,257 |
| 2021 | 16 | 2,089 | 2,930 | $332,935 | $129,950 |
| 2020 | 19 | 2,126 | 2,876 | $308,953 | $111,092 |
Total Patients
8,246
Total Services
11,061
Medicare Billing
$473,128
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 273 | 380 | $49,971 | $25,027 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 317 | 403 | $45,714 | $17,740 | 38.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 136 | 265 | $31,488 | $16,368 | 52.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 248 | 252 | $84,160 | $12,748 | 15.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 86 | 87 | $18,767 | $8,492 | 45.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 47 | $7,849 | $4,345 | 55.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 478 | 661 | $19,047 | $4,102 | 21.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 28 | $8,512 | $3,690 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 85 | $8,500 | $3,053 | 35.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $27,257 | $3,031 | 11.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 38 | 38 | $4,714 | $2,350 | 49.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 14 | $2,151 | $1,458 | 67.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 49 | $3,087 | $1,292 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $2,609 | $1,233 | 47.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 16 | $3,802 | $1,050 | 27.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 53 | 53 | $2,406 | $725.12 | 30.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Facility | 2023 | 28 | 81 | $18,642 | $560.52 | 3.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 13 | $935.00 | $471.12 | 50.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 17 | 17 | $933.00 | $447.20 | 47.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 45 | 45 | $1,321 | $393.84 | 29.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 13 | 13 | $676.00 | $250.32 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 251 | 355 | $36,130 | $24,180 | 66.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 167 | 349 | $37,800 | $19,667 | 52.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 277 | 281 | $103,408 | $14,280 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 224 | $22,610 | $14,171 | 62.7% |
About Dr. John Samsa, DO
Dr. John Samsa, DO is a Cardiovascular Disease healthcare provider based in Willoughby, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932168242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Samsa, DO has received a total of $2,120 in payments from pharmaceutical and medical device companies, with $64.01 received in 2024. These payments were reported across 49 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,367).
As a Medicare-enrolled provider, Samsa has provided services to 8,246 Medicare beneficiaries, totaling 11,061 services with total Medicare billing of $473,128. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Willoughby, OH
- Active Since 03/23/2006
- Last Updated 02/26/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1932168242
Products in Payments
- GENERAL THERAPIES (Device) $814.39
- Impella (Device) $208.43
- FFR LINK (Device) $168.63
- Mitra Clip system (Device) $156.44
- ENTRESTO (Drug) $146.47
- CoreValve Evolut (Device) $126.12
- XARELTO (Drug) $83.55
- SYNERGY (Device) $59.18
- ROTABLATOR (Device) $57.52
- Perclose ProGlide suture mediated closure system (Device) $47.31
- Supera peripheral stent system (Device) $24.43
- GENERAL STENTS (Device) $23.06
- WOLVERINE (Device) $21.80
- COMET (Device) $18.51
- ONYX FRONTIER (Device) $18.21
- BRILINTA (Drug) $16.50
- GENERAL ATHERECTOMY (Device) $15.76
- LEQVIO (Drug) $14.99
- Repatha (Biological) $14.55
- FARXIGA (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.